Tag: Zanubrutinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Zanubrutinib

Zanubrutinib Demonstrates Positive Results at Interim Analysis in Treating Chronic Lymphocytic ...

Added to Collection on: 2021-05-04 14:46:47

Tags for this article:

Health sciences
Orphan drugs
Chemical compounds
Health
Breakthrough therapy
Piperidines
Cardiac arrhythmia
Ibrutinib
BeiGene
Zanubrutinib
Bruton's tyrosine kinase
Clinical endpoint

Click the tags to see associated articles and topics

View Article Details
BeiGene Announces Acceptance by Swissmedic of Marketing Authorization Application for ...

Added to Collection on: 2021-08-18 04:52:30

Tags for this article:

Health sciences
Health
Orphan drugs
Breakthrough therapy
Piperidines
Drug discovery
Pharmaceutical industry
BeiGene
Ibrutinib
Mantle cell lymphoma
Waldenström's macroglobulinemia
Zanubrutinib
BeiGene Ltd.

Click the tags to see associated articles and topics

View Article Details
Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma - Targeted Oncology

Added to Collection on: 2021-10-23 19:16:21

Tags for this article:

Clinical medicine
Medicine
Health sciences
Orphan drugs
Breakthrough therapy
Antineoplastic drugs
Piperidines
Tyrosine kinase inhibitors
Mantle cell lymphoma
Ibrutinib
Bruton's tyrosine kinase
Zanubrutinib

Click the tags to see associated articles and topics

View Article Details
Global Bruton Tyrosine Kinase (BTK) Inhibitors Market | Key players are Pfizer Inc Acerta ...

Added to Collection on: 2022-06-06 19:19:20

Tags for this article:

Enzymes
Orphan drugs
Branches of biology
Drugs
Tyrosine kinase inhibitors
Breakthrough therapy
Bruton's tyrosine kinase
Zanubrutinib
Acalabrutinib
Tyrosine kinase
Chronic lymphocytic leukemia
Protein kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
Evolving Front-line Treatment Options for CLL - Cancer Network

Added to Collection on: 2023-12-18 22:08:57

Tags for this article:

Orphan drugs
Breakthrough therapy
Tyrosine kinase inhibitors
Tyrosine kinases
Piperidines
Bruton's tyrosine kinase
Acalabrutinib
Zanubrutinib
Obinutuzumab
Chronic lymphocytic leukemia
Lymphoid leukemia
Leukemia
Mayo Clinic

Click the tags to see associated articles and topics

View Article Details
Subgroup and Toxicity Analyses Favor Zanubrutinib Vs Ibrutinib in CLL - Targeted Oncology

Added to Collection on: 2024-06-10 21:22:27

Tags for this article:

Orphan drugs
Zanubrutinib
Ibrutinib
Bruton's tyrosine kinase
Chronic lymphocytic leukemia
Acalabrutinib
Obinutuzumab
CLL
Atrial fibrillation
Venetoclax
Atrial flutter
Indolent lymphoma

Click the tags to see associated articles and topics

View Article Details
Long-Term Data for Up-Front Combinations Reaffirm Treatment Options in CLL - OncLive

Added to Collection on: 2024-06-11 22:43:09

Tags for this article:

Orphan drugs
Acalabrutinib
Chronic lymphocytic leukemia
Obinutuzumab
Zanubrutinib
Leukemia
Ibrutinib
chlorambucil
Elevate

Click the tags to see associated articles and topics

View Article Details
Zanubrutinib Plus Venetoclax Generates 100% ORR in Treatment-Naive Del17p/TP53+ CLL/SLL

Added to Collection on: 2024-06-14 16:52:59

Tags for this article:

Orphan drugs
Antineoplastic drugs
Chloroarenes
Sulfonamides
Benzamides
Venetoclax
Zanubrutinib
Chronic lymphocytic leukemia
CLL
Richter's transformation

Click the tags to see associated articles and topics

View Article Details
Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia

Added to Collection on: 2024-06-14 13:07:54

Tags for this article:

Orphan drugs
Tyrosine kinase inhibitors
Piperidines
Antineoplastic drugs
Chronic lymphocytic leukemia
Acalabrutinib
Ibrutinib
Bruton's tyrosine kinase
Zanubrutinib
Obinutuzumab
Progression-free survival

Click the tags to see associated articles and topics

View Article Details
Novel Targeted Therapies Show Superiority in Relapsed/Refractory CLL

Added to Collection on: 2024-08-19 14:35:35

Tags for this article:

Orphan drugs
Antineoplastic drugs
Chronic lymphocytic leukemia
Ibrutinib
Phosphoinositide 3-kinase inhibitor
Venetoclax
Obinutuzumab
Zanubrutinib
Acalabrutinib
Rituximab
Targeted therapy
Bendamustine

Click the tags to see associated articles and topics

View Article Details